Search research articles
Contact Us
Filters
Showing results (81-90 of 84) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 84 results.
Angewandte Chemie (International Ed. in English)
|
February 22, 2023
When It's Heavier: Interfacial and Solvation Chemistry of Isotopes in Aqueous Electrolytes for Zn-ion Batteries
Xuan Gao, Yuhang Dai, Chengyi Zhang, et al.
Nature
|
January 31, 2024
Durable CO<sub>2</sub> conversion in the proton-exchange membrane system
Wensheng Fang, Wei Guo, Ruihu Lu, et al.
Nature
|
March 15, 2024
Publisher Correction: Durable CO<sub>2</sub> conversion in the proton-exchange membrane system
Wensheng Fang, Wei Guo, Ruihu Lu, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
Simon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 84) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 84 results.
Angewandte Chemie (International Ed. in English)
|
February 22, 2023
When It's Heavier: Interfacial and Solvation Chemistry of Isotopes in Aqueous Electrolytes for Zn-ion Batteries
Xuan Gao, Yuhang Dai, Chengyi Zhang, et al.
Nature
|
January 31, 2024
Durable CO<sub>2</sub> conversion in the proton-exchange membrane system
Wensheng Fang, Wei Guo, Ruihu Lu, et al.
Nature
|
March 15, 2024
Publisher Correction: Durable CO<sub>2</sub> conversion in the proton-exchange membrane system
Wensheng Fang, Wei Guo, Ruihu Lu, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR
Simon Planken, Douglas C Behenna, Sajiv K Nair, et al.
Page
of 9